American Oncology Network, Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
American Oncology Network, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • American Oncology Network, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$324K.
  • American Oncology Network, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $2.95M.
  • American Oncology Network, Inc. annual Income Tax Expense (Benefit) for 2023 was $384K.
  • American Oncology Network, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000, a 100% decline from 2021.
  • American Oncology Network, Inc. annual Income Tax Expense (Benefit) for 2021 was $460K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $384K +$384K Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $0 -$460K -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $460K +$1.24M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 -$783K Jan 1, 2020 Dec 31, 2020 8-K 2023-11-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.